Clinical trial

A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis

NCT00870467

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-03-01

PhasePHASE3

Study timeline

Study start (unknown)2009-03-01Date precision: month

Registry last updated2012-08-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

Double-blind adalimumabBIOLOGICAL

Double-blind PlaceboDRUG

Open-label AdalimumabBIOLOGICAL

Open-labelAdalimumabRescueBIOLOGICAL

Sponsors & collaborators

Abbottlead sponsor

Eisai Co., Ltd.collaborator

Mapped research locations

TokyoJapan10 ChibaJapan4 OkayamaJapan4 FukuokaJapan3 OsakaJapan2 HiroshimaJapan2 KyotoJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00870467 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.